Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease.

Klenske E, Atreya R, Hartmann A, Fischer S, Hirschmann S, Zundler S, Iaccuci M, Neurath MF, Rath T.

Endosc Int Open. 2019 Aug;7(8):E1018-E1026. doi: 10.1055/a-0953-1334. Epub 2019 Aug 8.

2.

Interferon lambda Promotes Paneth Cell Death via STAT1 Signaling in Mice and is Increased in Inflamed Ileal Tissues of Patients with Crohn's Disease.

Günther C, Ruder B, Stolzer I, Dorner H, He GW, Chiriac MT, Aden K, Strigli A, Bittel M, Zeissig S, Rosenstiel P, Atreya R, Neurath MF, Wirtz S, Becker C.

Gastroenterology. 2019 Jul 25. pii: S0016-5085(19)41128-1. doi: 10.1053/j.gastro.2019.07.031. [Epub ahead of print]

PMID:
31352002
3.

Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach.

Peyrin-Biroulet L, Danese S, Cummings F, Atreya R, Greveson K, Pieper B, Kang T.

Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):731-738. doi: 10.1080/17474124.2019.1645595. Epub 2019 Jul 26.

PMID:
31322440
4.

Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice.

López-Posadas R, Fastancz P, Martínez-Sánchez LDC, Panteleev-Ivlev J, Thonn V, Kisseleva T, Becker LS, Schulz-Kuhnt A, Zundler S, Wirtz S, Atreya R, Carlé B, Friedrich O, Schürmann S, Waldner MJ, Neufert C, Brakebusch CH, Bergö MO, Neurath MF, Atreya I.

Gastroenterology. 2019 Jul 11. pii: S0016-5085(19)41087-1. doi: 10.1053/j.gastro.2019.07.007. [Epub ahead of print]

5.

Targeting mucosal healing in Crohn's disease: what the clinician needs to know.

Klenske E, Bojarski C, Waldner M, Rath T, Neurath MF, Atreya R.

Therap Adv Gastroenterol. 2019 Jun 14;12:1756284819856865. doi: 10.1177/1756284819856865. eCollection 2019. Review.

6.

Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing.

Schleier L, Wiendl M, Heidbreder K, Binder MT, Atreya R, Rath T, Becker E, Schulz-Kuhnt A, Stahl A, Schulze LL, Ullrich K, Merz SF, Bornemann L, Gunzer M, Watson AJM, Neufert C, Atreya I, Neurath MF, Zundler S.

Gut. 2019 May 15. pii: gutjnl-2018-316772. doi: 10.1136/gutjnl-2018-316772. [Epub ahead of print]

PMID:
31092589
7.

Oligonucleotides-A Novel Promising Therapeutic Option for IBD.

Scarozza P, Schmitt H, Monteleone G, Neurath MF, Atreya R.

Front Pharmacol. 2019 Apr 24;10:314. doi: 10.3389/fphar.2019.00314. eCollection 2019. Review.

8.

Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases.

Ruder B, Atreya R, Becker C.

Int J Mol Sci. 2019 Apr 16;20(8). pii: E1887. doi: 10.3390/ijms20081887. Review.

9.

Comparison of Hemospray® and Endoclot for the treatment of gastrointestinal bleeding.

Vitali F, Naegel A, Atreya R, Zopf S, Neufert C, Siebler J, Neurath MF, Rath T.

World J Gastroenterol. 2019 Apr 7;25(13):1592-1602. doi: 10.3748/wjg.v25.i13.1592.

10.

Author Correction: Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation.

Zundler S, Becker E, Spocinska M, Slawik M, Parga-Vidal L, Stark R, Wiendl M, Atreya R, Rath T, Leppkes M, Hildner K, López-Posadas R, Lukassen S, Ekici AB, Neufert C, Atreya I, van Gisbergen KPJM, Neurath MF.

Nat Immunol. 2019 Apr;20(4):514. doi: 10.1038/s41590-019-0360-y.

PMID:
30846879
11.

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease.

Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, Klenske E, Erickson R, Chiu H, Reed C, Chung S, Neufert C, Atreya I, McBride J, Neurath MF, Zundler S.

Front Pharmacol. 2019 Feb 1;10:39. doi: 10.3389/fphar.2019.00039. eCollection 2019.

12.

Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation.

Zundler S, Becker E, Spocinska M, Slawik M, Parga-Vidal L, Stark R, Wiendl M, Atreya R, Rath T, Leppkes M, Hildner K, López-Posadas R, Lukassen S, Ekici AB, Neufert C, Atreya I, van Gisbergen KPJM, Neurath MF.

Nat Immunol. 2019 Mar;20(3):288-300. doi: 10.1038/s41590-018-0298-5. Epub 2019 Jan 28. Erratum in: Nat Immunol. 2019 Apr;20(4):514.

PMID:
30692620
13.

Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS).

Authors; Collaborators:.

Z Gastroenterol. 2019 Feb;57(2):162-241. doi: 10.1055/a-0824-0861. Epub 2019 Jan 17.

PMID:
30654406
14.

Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.

Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carlé B, Knieling F, Claussen J, Klimowicz AC, Zheng J, Baum P, Meyer S, Schürmann S, Friedrich O, Waldner MJ, Rath T, Wirtz S, Kollias G, Ekici AB, Atreya R, Raymond EL, Mbow ML, Neurath MF, Neufert C.

Gastroenterology. 2019 Mar;156(4):1082-1097.e11. doi: 10.1053/j.gastro.2018.11.029. Epub 2018 Nov 16.

PMID:
30452921
15.

Cap polyposis in children: case report and literature review.

Brunner M, Agaimy A, Atreya R, Grützmann R, Matzel KE.

Int J Colorectal Dis. 2019 Feb;34(2):363-368. doi: 10.1007/s00384-018-3192-6. Epub 2018 Nov 13. Review.

PMID:
30426196
16.

Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn's Disease.

Klenske E, Osaba L, Nagore D, Rath T, Neurath MF, Atreya R.

J Crohns Colitis. 2019 Feb 1;13(2):267-269. doi: 10.1093/ecco-jcc/jjy153.

PMID:
30388211
17.

Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease.

Atreya R, Neurath MF.

Lancet Gastroenterol Hepatol. 2018 Nov;3(11):790-802. doi: 10.1016/S2468-1253(18)30265-6. Review.

PMID:
30353856
18.

Successful Long-term Treatment of Diversion Colitis with Topical Coconut Oil Application.

Zundler S, Dietz L, Matzel KE, Geppert CI, Becker E, Rath T, Neurath MF, Atreya R.

Am J Gastroenterol. 2018 Dec;113(12):1908-1910. doi: 10.1038/s41395-018-0394-z. Epub 2018 Oct 23. No abstract available.

PMID:
30353052
19.

[Updated S3-Guideline Colitis ulcerosa. German Society for Digestive and Metabolic Diseases (DGVS) - AWMF Registry 021/009].

Authors; Collaborators:.

Z Gastroenterol. 2018 Sep;56(9):1087-1169. doi: 10.1055/a-0651-8174. Epub 2018 Sep 11. German.

20.

Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases.

Rath T, Billmeier U, Ferrazzi F, Vieth M, Ekici A, Neurath MF, Atreya R.

Front Immunol. 2018 Jul 31;9:1700. doi: 10.3389/fimmu.2018.01700. eCollection 2018.

Supplemental Content

Loading ...
Support Center